Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease

被引:0
作者
Whittaker, Hannah [1 ]
Kallis, Constantinos [1 ]
Bolton, Thomas [2 ,3 ,4 ]
Wood, Angela [2 ,5 ]
Walker, Samantha [3 ,4 ]
Sheikh, Aziz [6 ]
Brownrigg, Alex [7 ]
Akbari, Ashley [8 ]
Sterniczuk, Kamil [7 ]
Quint, Jennifer K. [1 ]
机构
[1] Imperial Coll London, Sch Publ Hlth, Resp EHR, London, England
[2] Hlth Data Res UK, British Heart Fdn, Data Sci Ctr, London, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England
[4] Asthma Lung, London, England
[5] Univ Cambridge, British Heart Fdn, Cardiovasc Epidemiol Unit, Cambridge, England
[6] Univ Edinburgh, Usher Inst, Edinburgh, Scotland
[7] BREATHE, Hlth Data Res UK, London, England
[8] Swansea Univ, Swansea Univ Med Sch, Populat Data Sci, Swansea, Wales
关键词
COVID-19; COPD; asthma; cardiovascular disease; OBSTRUCTIVE PULMONARY-DISEASE; HEART-FAILURE; ASTHMA; EXACERBATIONS; INFLAMMATION; ADULTS;
D O I
10.1093/ije/dyae068
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background COVID-19 is associated with cardiovascular outcomes in the general population, but it is unknown whether people with chronic respiratory disease (CRD) have a higher risk of cardiovascular events post-COVID-19 compared with the general population and, if so, what respiratory-related factors may modify this risk in these people.Methods Primary and secondary care data from the National Health Service England were used to define a population of adults in England with COVID-19 (index date) between 1 January 2020 and 30 November 2021. Adjusted Cox proportional hazard regression was used to quantify the association between CRD, asthma-related factors, chronic obstructive pulmonary disease (COPD)-related factors, and risk of cardiovascular events. Asthma-specific factors included baseline asthma control, exacerbations, and inhaled corticosteroid (ICS) dose. COPD-specific risk factors included baseline ICS and exacerbations. Secondary objectives quantified the impact of COVID-19 hospitalisation and vaccine dose on cardiovascular outcomes.Results Of 3 670 455 people, those with CRD had a higher risk of cardiovascular events [adjusted hazard ratio (HRadj), 1.08; 95% confidence interval (CI) 1.06-1.11], heart failure (HRadj, 1.17; 95% CI, 1.12-1.22), angina (HRadj, 1.13; 95% CI, 1.06-1.20) and pulmonary emboli (HRadj, 1.24; 95% CI, 1.15-1.33) compared with people without CRD. In people with asthma or COPD, baseline exacerbations were associated with a higher risk of cardiovascular outcomes (HRadj, 1.36; 95% CI, 1.27-1.00 and HRadj, 1.35; 95% CI, 1.24-1.46, respectively). Regardless of CRD, the risk of cardiovascular events was lower with increasing COVID-19 vaccine dose.Conclusions Higher risk of cardiovascular events post-COVID-19 might be explained by the underlying severity of the CRD, and COVID-19 vaccines were beneficial to both people with and those without CRD with regards to cardiovascualr events.
引用
收藏
页数:10
相关论文
共 33 条
  • [1] Predictors of cardiovascular disease in asthma and chronic obstructive pulmonary disease
    Bellocchia, Michela
    Masoero, Monica
    Ciuffreda, Antonio
    Croce, Silvia
    Vaudano, Arianna
    Torchio, Roberto
    Boita, Monica
    Bucca, Caterina
    [J]. MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2013, 8
  • [2] Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study
    Chung, Wei-Sheng
    Lin, Cheng-Li
    Ho, Feng-Ming
    Li, Ruei-Yuan
    Sung, Fung-Chang
    Kao, Chia-Hung
    Yeh, Jun-Jun
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (03) : 801 - 807
  • [3] Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction
    Clarson, Lorna Elise
    Bajpai, Ram
    Whittle, Rebecca
    Belcher, John
    Abdul Sultan, Alyshah
    Kwok, Chun Shing
    Welsh, Victoria
    Mamas, Mamas
    Mallen, Christian D.
    [J]. HEART, 2020, 106 (12) : 916 - 922
  • [4] Asthma and stroke: a narrative review
    A. Corlateanu
    Iu Stratan
    S. Covantev
    V. Botnaru
    O. Corlateanu
    N. Siafakas
    [J]. Asthma Research and Practice, 7 (1)
  • [5] Chronic Heart Failure and Inflammation What Do We Really Know?
    Dick, Sarah A.
    Epelman, Slava
    [J]. CIRCULATION RESEARCH, 2016, 119 (01) : 159 - 176
  • [6] Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
    Dransfield, Mark T.
    Criner, Gerard J.
    Halpin, David M. G.
    Han, MeiLan K.
    Hartley, Benjamin
    Kalhan, Ravi
    Lange, Peter
    Lipson, David A.
    Martinez, Fernando J.
    Midwinter, Dawn
    Singh, Dave
    Wise, Robert
    Kunisaki, Ken M.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
  • [7] Global Initiative for Asthma (GINA), 2023, Global strategy for asthma management and prevention
  • [8] Incidence and Impact of Pulmonary Embolism During Severe COPD Exacerbation
    Hassen, Mohamed Fekih
    Tilouche, Nejla
    Jaoued, Oussama
    Elatrous, Souheil
    [J]. RESPIRATORY CARE, 2019, 64 (12) : 1531 - 1536
  • [9] Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection
    Kim, Young-Eun
    Huh, Kyungmin
    Park, Young-Joon
    Peck, Kyong Ran
    Jung, Jaehun
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (09): : 887 - 889
  • [10] Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
    Knight, Rochelle
    Walker, Venexia
    Ip, Samantha
    Cooper, Jennifer A.
    Bolton, Thomas
    Keene, Spencer
    Denholm, Rachel
    Akbari, Ashley
    Abbasizanjani, Hoda
    Torabi, Fatemeh
    Omigie, Efosa
    Hollings, Sam
    North, Teri-Louise
    Toms, Renin
    Jiang, Xiyun
    Di Angelantonio, Emanuele
    Denaxas, Spiros
    Thygesen, Johan H.
    Tomlinson, Christopher
    Bray, Ben
    Smith, Craig J.
    Barber, Mark
    Khunti, Kamlesh
    Smith, George Davey
    Chaturvedi, Nishi
    Sudlow, Cathie
    Whiteley, William N.
    Wood, Angela M.
    Sterne, Jonathan A. C.
    [J]. CIRCULATION, 2022, 146 (12) : 892 - 906